Insiders Adhera Therapeutics, Inc.

Equities

ATRX

US00687E4061

Market Closed - OTC Markets Other stock markets 20:46:57 10/06/2024 BST			5-day change	1st Jan Change
0.0042 ^USD	+2.44%		+7.69%	-86.00%

01-18	Adhera Therapeutics, Inc. Receives Written Notice from Melior Pharmaceuticals II, LLC of Election to Terminate the License Agreement	CI
01-16	Adhera Therapeutics, Inc. Announces the Resignation of Zahed Subhan as Chief Executive Officer	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Adhera Therapeutics, Inc. Announces the Resignation of Zahed Subhan as Chief Executive Officer	01-16	CI
Adhera Therapeutics, Inc. Announces Board Resignations	01-16	CI
Adhera Therapeutics, Inc. Elects Zahed Subhan as Chairman of the Board	19/09/22	CI
Adhera Therapeutics, Inc. Announces CEO Changes, Effective September 30, 2022	09/09/22	CI
Adhera Therapeutics, Inc. Appoints Andrew Kucharchuk as Chief Operating Officer, Effective September 30, 2022	09/09/22	CI
Adhera Therapeutics, Inc. Appoints Trond K. Waerness as Chairman of the Board	19/05/22	CI
Adhera Therapeutics, Inc. Appoints Jean Buteau to Scientific Advisory Board	21/03/22	CI
Adhera Therapeutics, Inc. Announces Appointment of Zahed Subhan to its Board of Directors	08/11/21	CI
Adhera Therapeutics, Inc. Appoints Andrew G. Reaume to Board of Directors	09/09/21	CI
Adhera Therapeutics, Inc. Appoints Trond K. Waerness as Member of its Board of Directors	23/04/21	CI
Adhera Therapeutics, Inc. Appoints Andrew Kucharchuk as the Chief Executive Officer	13/07/20	CI
Adhera Therapeutics, Inc. Announces Management Changes	13/07/20	CI
Adhera Therapeutics, Inc. Announces Resignation of Rhonda Stanley, Senior Vice President of Finance & Accounting	13/07/20	CI
Adhera Therapeutics, Inc. Announces Resignation of Tim Boris as Member of the Board of Directors and All Committees	17/06/20	CI
Adhera Therapeutics, Inc. Announces Nancy R. Phelan Has Resigned as Chief Executive Officer, Effective June 15, 2020	11/06/20	CI
Adhera Therapeutics, Inc. announces management changes, effective June 15, 2020	11/06/20	CI
Nancy R. Phelan Replaces Robert C. Moscato as Chief Executive Officer of Adhera Therapeutics, Inc	04/04/19	CI
Adhera Therapeutics, Inc. Announces Resignation of Eric Teague as Chief Financial Officer, Effective March 22, 2019	15/03/19	CI
Adhera Therapeutics, Inc. Announces Resignation of Erik Emerson as Chief Commercial Officer	22/01/19	CI
Marina Biotech, Inc. will Change its Name to Adhera Therapeutics Inc	09/10/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Adhera Therapeutics, Inc.

Equities

ATRX

US00687E4061

Insiders

Filters